Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Top Performance

Predictions

buy
aTyr Pharma Inc

Start price
Target price
Perf. (%)
€1.66
14.04.24
-
14.04.25
-13.86%
28.04.24

Could be worthwhile Investment >10% per year
thomasw 
14.04.24 50%
buy
Fate Therapeutics Inc.

Start price
Target price
Perf. (%)
€3.60
25.04.24
-
25.04.25
-2.00%
27.04.24

Could be worthwhile Investment >10% per year
Global_Player 
25.04.24 50%
sell
iBio Inc.

Start price
Target price
Perf. (%)
€0.99
26.04.23
€0.20
26.04.24
-81.42%
27.04.24

Capable Management
Good culture
Valuable balance sheet
Dependend from some customers or products
geldnutzer 
26.04.23 60%
sell
Advaxis Inc.

Start price
Target price
Perf. (%)
€0.059
26.04.23
-
26.04.24
-
27.04.24

StockNews.com 
26.04.23 50%
sell
Ampio Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€0.060
26.04.23
-
26.04.24
-
27.04.24

StockNews.com 
26.04.23 50%
buy
Arrowhead Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€30.42
26.04.23
€72.10
26.04.24
-32.54%
27.04.24

Sumitomo Mitsui Financial Group, Inc. 
26.04.23 50%
sell
Adaptimmune Therapeutics PLC ADR

Start price
Target price
Perf. (%)
€1.07
13.04.24
€1.00
13.04.25
-2.80%
27.04.24

Probably not worthwhile Investment
Lower EBIT Margin than peer group
Bad rating
ROE lower than 10% per year
nvestor 
13.04.24 50%
sell
Inotiv Inc.

Start price
Target price
Perf. (%)
€5.50
13.04.24
€4.00
13.04.25
-32.36%
27.04.24

Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Little Investments for future growth
nvestor 
13.04.24 50%
sell
Enlivex Therapeutics Ltd.

Start price
Target price
Perf. (%)
€1.51
13.04.24
€2.00
13.04.25
-0.66%
27.04.24

negative Cash Flow expected
Few uniques
Growths slower than the competition
Below average Marketposition
nvestor 
13.04.24 50%
buy
Amgen Inc.

Start price
Target price
Perf. (%)
€222.60
24.04.23
€263.03
24.04.24
15.03%
25.04.24

Oppenheimer Holdings Inc. 
24.04.23 50%
buy
Geron Corp.

Start price
Target price
Perf. (%)
€2.40
24.04.23
€3.63
24.04.24
37.50%
25.04.24

Needham & Company LLC 
24.04.23 50%
buy
Heron Therapeutics Inc.

Start price
Target price
Perf. (%)
€2.40
24.04.23
€6.35
24.04.24
-5.00%
25.04.24

Needham & Company LLC 
24.04.23 50%
sell
Trevena Inc.

Start price
Target price
Perf. (%)
€0.82
23.04.23
-
23.04.24
-60.39%
24.04.24

StockNews.com 
23.04.23 50%
sell
Bellicum Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€0.21
22.04.23
-
22.04.24
-22.38%
23.04.24

StockNews.com 
22.04.23 50%
sell
Cellectar BioSciences Inc.

Start price
Target price
Perf. (%)
€1.32
22.04.23
-
22.04.24
127.27%
23.04.24

StockNews.com 
22.04.23 50%
sell
Cyclacel Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€0.51
22.04.23
-
22.04.24
-66.04%
23.04.24

StockNews.com 
22.04.23 50%
sell
Genocea Biosciences Inc.

Start price
Target price
Perf. (%)
€0.009
22.04.23
-
22.04.24
-
23.04.24

StockNews.com 
22.04.23 50%
buy
Natural Alternat.

Start price
Target price
Perf. (%)
€7.95
22.04.23
-
22.04.24
-27.04%
23.04.24

StockNews.com 
22.04.23 50%
sell
Neptune Wellness Solutions Inc

Start price
Target price
Perf. (%)
€0.55
22.04.23
-
22.04.24
-76.33%
23.04.24

StockNews.com 
22.04.23 50%
sell
Nymox Pharmaceutical Corp.

Start price
Target price
Perf. (%)
€0.41
22.04.23
-
22.04.24
-43.90%
23.04.24

StockNews.com 
22.04.23 50%
buy
Trinity Biotech ADR

Start price
Target price
Perf. (%)
€0.91
22.04.23
-
22.04.24
-52.75%
23.04.24

StockNews.com 
22.04.23 50%
buy
EyePoint Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€5.40
20.04.23
-
20.04.24
205.00%
21.04.24

Robert W. Baird 
20.04.23 50%
buy
Abbott Laboratories

Start price
Target price
Perf. (%)
€101.24
20.04.23
€111.01
20.04.24
-0.75%
21.04.24

JPMorgan Chase & Co. 
20.04.23 50%
buy
Abbott Laboratories

Start price
Target price
Perf. (%)
€101.24
20.04.23
€121.02
20.04.24
-0.75%
21.04.24

Sanford C. Bernstein 
20.04.23 50%
sell
Abbott Laboratories

Start price
Target price
Perf. (%)
€101.24
20.04.23
€93.72
20.04.24
-0.75%
21.04.24

Wolfe Research 
20.04.23 50%